Oxford City Council’s planning committee has granted planning permission for the Oxford North £700m mixed-use development in the UK to continue.
This mixed-use project includes three laboratories, office buildings covering an area of one million square feet, housing units, a nursery, three public parks, and associated infrastructure.
Phase 1a of this project will see the development of the Red Hall, which includes 43,500ft² of coworking spaces, meeting and workplaces for science and innovation startups and small and medium-sized enterprises, as well as extra community space.
Phase 1a is scheduled to be completed in the first quarter (Q1) of 2025.
The aforementioned laboratory and office buildings, meanwhile, will be developed as part of the project’s phase two.
Divided into Plots A, B, and C, phase two includes the construction of the three laboratory buildings’ look, layouts, low-carbon operating measures, and improvements to the main and building-specific landscaping.
Fletcher Priest Architects, the master planner of this project, designed Plot A, an adaptable, four-storey laboratory and office facility with dual frontage to the A40 and central landscaping totalling 117,300ft².
Wilkinson Eyre designed Plot B, a 177,900ft², five-storey global headquarters laboratory and office complex, also with A40 frontage.
Finally, Plot C, designed by Gort Scott, is a five-storey global headquarters laboratory and office complex comprising an area of 162,900ft². It will be located inside the central area of the site, opposite the Red Hall and Market Square.
These three buildings will aim for the BREEAM Excellent certification and include solar photovoltaic technology, heat recovery systems, high levels of fabric performance, and 100% electric heating and cooling.
Savills Oxford head Charles Rowton-Lee said: “Demand for lab space in Oxfordshire is currently circa 1.2 million square feet with just 5,000ft² of current supply.
“The delivery of Oxford North’s first five new lab buildings will be a significant boost for both local and global life sciences companies to accelerate their discoveries here in Oxford.
“We are already in initial discussions with companies looking for such space, and today’s news means these conversations can be advanced.”